Who Exports Alprazolam from India — 39 Suppliers Behind a $16.6M Market
India's alprazolam export market is supplied by 39 active exporters who collectively shipped $16.6M across 654 shipments. WATSON PHARMA PRIVATE LIMITED leads with a 46.5% market share, followed by SANDOZ PRIVATE LIMITED and AUROBINDO PHARMA LIMITED. The top 5 suppliers together control 82.2% of total export value, reflecting a concentrated market structure.
Top Alprazolam Exporters from India — Ranked by Export Value
WATSON PHARMA PRIVATE LIMITED is the leading alprazolam exporter from India, holding a 46.5% share of the $16.6M market across 654 shipments from 39 exporters. The top 5 suppliers — WATSON PHARMA PRIVATE LIMITED, SANDOZ PRIVATE LIMITED, AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA LTD, WATSON PHARMA PVT LTD — collectively control 82.2% of total export value, indicating a highly concentrated market. Individual shares are: WATSON PHARMA PRIVATE LIMITED (46.5%), SANDOZ PRIVATE LIMITED (12.2%), AUROBINDO PHARMA LIMITED (11.8%), AUROBINDO PHARMA LTD (7.3%), WATSON PHARMA PVT LTD (4.4%).
Top Alprazolam Exporters from India
Ranked by export value · 39 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | WATSON PHARMA PRIVATE LIMITED ALPRAZOLAM USP 1.0MG 500TAB BO US, MATERIAL NO. - 107905ALPRAZOLAM TABLETS USP 0.25 MG (ALPRAZOLAM TABLETS USP 1 MG | $7.7M | 1 | 46.5% |
| 2 | SANDOZ PRIVATE LIMITED ALPRAZOLAM USP 1.0MG 500TAB BO US, MATERIAL NO. - 107905ALPRAZOLAM TABLETS USP 0.25 MG (ALPRAZOLAM TABLETS USP 1 MG | $2.0M | 1 | 12.2% |
| 3 | AUROBINDO PHARMA LIMITED ALPRAZOLAM USP 1.0MG 500TAB BO US, MATERIAL NO. - 107905ALPRAZOLAM TABLETS USP 0.25 MG (ALPRAZOLAM TABLETS USP 1 MG | $2.0M | 3 | 11.8% |
| 4 | AUROBINDO PHARMA LTD ALPRAZOLAM USP 1.0MG 500TAB BO US, MATERIAL NO. - 107905ALPRAZOLAM TABLETS USP 0.25 MG (ALPRAZOLAM TABLETS USP 1 MG | $1.2M | 4 | 7.3% |
| 5 | WATSON PHARMA PVT LTD ALPRAZOLAM USP 1.0MG 500TAB BO US, MATERIAL NO. - 107905ALPRAZOLAM TABLETS USP 0.25 MG (ALPRAZOLAM TABLETS USP 1 MG | $736.7K | 1 | 4.4% |
| 6 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED | $630.0K | 1 | 3.8% |
| 7 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED MANOREST 0.25MG TABLETS ALPRAZOLAM (TABLALPRAZOLAM TABLETS USP 0.5 MG PACK : 10*1014315*10*10 1431500 TABLETS OF ALPRAZOLAM 0.5 MG NOS | $620.9K | 5 | 3.7% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED MANOREST 0.25MG TABLETS ALPRAZOLAM (TABLALPRAZOLAM TABLETS USP 0.5 MG PACK : 10*1014315*10*10 1431500 TABLETS OF ALPRAZOLAM 0.5 MG NOS | $592.4K | 2 | 3.6% |
| 9 | TORRENT PHARMACEUTICALS LTD ALTROX 500 TABLETSALTROX 250 TABLETS ALPRAZOLAM 250 MCGNOS=10X10 TABALTROX 250 TABLETS | $429.4K | 1 | 2.6% |
| 10 | ORCHID PHARMA LIMITED MANOREST 0.25MG TABLETS ALPRAZOLAM (TABLALPRAZOLAM TABLETS USP 0.5 MG PACK : 10*1014315*10*10 1431500 TABLETS OF ALPRAZOLAM 0.5 MG NOS | $155.6K | 1 | 0.9% |
| 11 | SWISS PARENTERALS LIMITED XAPRAZOLAM 0.5 ALPRAZOLAM TABLETS USP 0.5 MGXAPRAZOLAM 0.5 ALPRAZOLAM TABLETS USP 0.XAPRAZOLAM 0.25 ALPRAZOLAM TABLETS USP 0 | $109.7K | 1 | 0.7% |
| 12 | SYNMEDIC LABORATORIES MANOREST 0.25MG TABLETS ALPRAZOLAM (TABLALPRAZOLAM TABLETS USP 0.5 MG PACK : 10*1014315*10*10 1431500 TABLETS OF ALPRAZOLAM 0.5 MG NOS | $64.4K | 1 | 0.4% |
| 13 | TORRENT PHARMACEUTICALS LIMITED ALTROX 500 TABLETSALTROX 250 TABLETS ALPRAZOLAM 250 MCGNOS=10X10 TABALTROX 250 TABLETS | $63.1K | 1 | 0.4% |
| 14 | PAR FORMULATIONS PRIVATE LIMITED ALPRAZOLAM USP 1.0MG 500TAB BO US, MATERIAL NO. - 107905ALPRAZOLAM TABLETS USP 0.25 MG (ALPRAZOLAM TABLETS USP 1 MG | $59.0K | 1 | 0.4% |
Related Analysis
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Alprazolam sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous API manufacturers, contributing significantly to India's pharmaceutical exports. Companies like Granules India, headquartered in Hyderabad, are involved in the manufacture and sale of APIs and finished dosage forms.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara belt in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to companies like Alembic Pharmaceuticals, which manufactures and markets pharmaceutical products, including APIs and formulations. The concentration of formulation units in this area underscores its importance in the production of finished pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for Indian pharmaceuticals. Mumbai, being a major port city, facilitates the export of pharmaceutical products to international markets. Companies like Sun Pharmaceutical Industries, headquartered in Mumbai, manufacture and sell pharmaceutical formulations and APIs in more than 100 countries. The strategic location and infrastructure of this region make it a pivotal point for pharmaceutical exports.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. This region hosts numerous pharmaceutical units, contributing to the overall production capacity of the country. The tax benefits have attracted many companies to set up manufacturing facilities here, enhancing the region's role in the pharmaceutical supply chain.
5Sourcing Recommendations
- Diversify Supplier Base: Given the concentration of Alprazolam exports among a few key players, it's advisable to diversify the supplier base to mitigate risks associated with over-reliance on a limited number of suppliers.
- Evaluate Manufacturing Clusters: Assess the capabilities of manufacturers in different clusters, such as Hyderabad for APIs and Ahmedabad-Vadodara for formulations, to identify the most suitable partners based on specific requirements.
- Ensure Regulatory Compliance: Prioritize suppliers with a strong track record of regulatory compliance, especially those with approvals from agencies like the FDA, EMA, and CDSCO, to ensure product quality and facilitate smoother export processes.
- Monitor Export Trends: Keep abreast of export data and trends to identify emerging suppliers and markets, enabling proactive adjustments to sourcing strategies in response to market dynamics.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Alprazolam exporters from India
Sandoz Group AG — Sandoz spins off from Novartis to become independent
On October 4, 2023, Novartis completed the spin-off of Sandoz, establishing it as a standalone company. - IMPACT: This strategic move may enhance Sandoz's focus on generic pharmaceuticals, potentially affecting its Alprazolam export strategies.
Impact: This strategic move may enhance Sandoz's focus on generic pharmaceuticals, potentially affecting its Alprazolam export strategies.
Aurobindo Pharma Limited — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing
In May 2024, TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: This collaboration may lead to increased production capabilities, potentially influencing Aurobindo's Alprazolam export capacity.
Impact: This collaboration may lead to increased production capabilities, potentially influencing Aurobindo's Alprazolam export capacity.
Sandoz Group AG — Sandoz acquires Just-Evotec Biologics to enhance manufacturing
In November 2025, Sandoz announced a strategic agreement with Evotec to acquire Just-Evotec Biologics, including its biologics manufacturing facility in Toulouse, France. - IMPACT: This acquisition is expected to bolster Sandoz's manufacturing capabilities, which may impact its Alprazolam production and export strategies.
Impact: This acquisition is expected to bolster Sandoz's manufacturing capabilities, which may impact its Alprazolam production and export strategies.
Common Questions — Alprazolam Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which alprazolam supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, WATSON PHARMA PRIVATE LIMITED leads with 235 recorded shipments worth $7.7M. SANDOZ PRIVATE LIMITED (60 shipments) and AUROBINDO PHARMA LIMITED (76 shipments) are also established high-volume exporters.
Q How many alprazolam manufacturers are there in India?
India has 39 active alprazolam exporters with a combined export market of $16.6M across 654 shipments to 24 countries. The top 5 suppliers hold 82.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for alprazolam from India?
Average FOB unit price: $16.79 per unit, ranging from $0.00 to $47.87. Average shipment value: $25.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 39 verified Indian exporters of Alprazolam ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 654 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 24 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
654 Verified Shipments
39 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists